EX-8 3 drr0394_ex8.htm EXHIBIT 8



Dr. Reddy’s Laboratories Limited


Dr. Reddy’s Laboratories Limited is the parent company. Tabulated below is the list of subsidiaries and joint ventures as of March 31, 2022:


Name of the subsidiary/joint ventureCountry of Incorporation

Percentage of

Direct/Indirect Ownership


Aurigene Discovery Technologies (Malaysia) Sdn. Bhd. Malaysia100%(3)
Aurigene Discovery Technologies LimitedIndia100%
Aurigene Pharmaceutical Services Limited (from September 16, 2019)India100%(3)
beta Institut gemeinnützige GmbHGermany100%(8)
betapharm Arzneimittel GmbH Germany100%(8)
Cheminor Investments Limited India100%
Cheminor Employees Welfare TrustIndiaRefer to below footnote(15)
Chirotech Technology LimitedUnited Kingdom100%(2)(5)
Dr. Reddy’s Research FoundationIndiaRefer to below footnote(15)
Dr. Reddy's Employees ESOS Trust IndiaRefer to below footnote(15)
Dr. Reddy’s Farmaceutica Do Brasil Ltda. Brazil100%
Dr. Reddy’s Laboratories (EU) Limited United Kingdom100%(10)
Dr. Reddy’s Laboratories (Proprietary) Limited South Africa100%(10)
Dr. Reddy’s Laboratories (UK) Limited United Kingdom100%(5)
Dr. Reddy’s Laboratories Canada, Inc. Canada100%(10)
Dr. Reddy's Laboratories Chile SPA. Chile100%(10)
Dr. Reddy’s Laboratories, Inc.U.S.A.100%(10)
Dr. Reddy’s Laboratories Japan KKJapan100%(10)
Dr. Reddy’s Laboratories Kazakhstan LLP Kazakhstan100%(10)
Dr. Reddy’s Laboratories Louisiana, LLC U.S.A.100%(6)
Dr. Reddy’s Laboratories Malaysia Sdn. Bhd. Malaysia100%(10)
Dr. Reddy’s Laboratories New York, LLC U.S.A.100%(1)
Dr. Reddy’s Laboratories Philippines Inc.Philippines100%(10)
Dr. Reddy’s Laboratories Romania S.R.L. Romania100%(10)
Dr. Reddy’s Laboratories SASwitzerland100%
Dr. Reddy’s Laboratories Taiwan Limited Taiwan100%(10)
Dr. Reddy’s Laboratories (Thailand) Limited Thailand100%(10)
Dr. Reddy’s Laboratories, LLC Ukraine100%(10)
Dr. Reddy’s New Zealand LimitedNew Zealand100%(10)
Dr. Reddy’s S.R.L.Italy100%(11)
Dr. Reddy’s Bio-Sciences Limited India100%
Dr. Reddy’s Laboratories (Australia) Pty. Limited Australia100%(10)
Dr. Reddy’s Laboratories S.A.S. Colombia100%(10)
Dr. Reddy’s Research and Development B.V. Netherlands100%(12)
Dr. Reddy’s Venezuela, C.A. Venezuela100%(10)
Dr. Reddy’s (WUXI) Pharmaceutical Company Limited China100%(2)(10)
Dr. Reddy’s (Beijing) Pharmaceutical Co. Limited (from August 19, 2020)China100%(10)
DRES Energy Private Limited India26%(14)
DRL Impex LimitedIndia100%(13)
Dr. Reddy’s Laboratories B.V. Netherlands100%(12)
Dr. Reddy’s Formulations Limited (from March 11, 2021)India100%
Idea2Enterprises (India) Private LimitedIndia100%
Imperial Credit Private Limited India100%
Industrias Quimicas Falcon de Mexico, S.A. de CVMexico100%
Kunshan Rotam Reddy Pharmaceutical Co. Limited China51.33%(4)
Lacock Holdings LimitedCyprus100%(10)
Nimbus Health, GmbH (from February 24, 2022)Germany100%(8)
Dr. Reddy’s Laboratories LLCRussia100%(10)
DRS LLCRussia100%(9)



Organizational structure (continued)

Name of the subsidiary/joint ventureCountry of IncorporationPercentage of Direct/Indirect Ownership Interest
Promius Pharma, LLCU.S.A.100%(6)
Reddy Holding GmbH Germany100%(10)
Reddy Netherlands B.V. Netherlands100%(10)
Reddy Pharma Iberia S.A.U.Spain100%(10)
Reddy Pharma Italia S.R.L. Italy100%(7)
Reddy Pharma SAS France100%(10)
Svaas Wellness Limited India100%

Aurigene Discovery Technologies, Inc.







(1)Indirectly owned through Dr. Reddy’s Laboratories, Inc. (from October 29, 2020), formerly a subsidiary of Dr. Reddy’s Laboratories SA. Also, conversion from corporation to limited liability company is effective October 30, 2020.


(2)Entity under liquidation.


(3)Indirectly owned through Aurigene Discovery Technologies Limited.


(4)Kunshan Rotam Reddy Pharmaceutical Co. Limited is a subsidiary as per Indian Companies Act, 2013, as the Company holds a 51.33% stake. However, the Company accounts for this investment by the equity method and does not consolidate it in the Company’s financial statements.


(5)Indirectly owned through Dr. Reddy’s Laboratories (EU) Limited.


(6)Indirectly owned through Dr. Reddy’s Laboratories Inc.


(7)Indirectly owned through Lacock Holdings Limited.


(8)Indirectly owned through Reddy Holding GmbH.


(9)Indirectly owned through Dr. Reddy’s Laboratories LLC, Russia.


(10)Indirectly owned through Dr. Reddy’s Laboratories SA.


(11)Indirectly owned through Reddy Pharma Italia S.R.L.


(12)Indirectly owned through Reddy Netherlands B.V.


(13)Indirectly owned through Idea2Enterprises (India) Pvt. Limited.


(14)Accounted in accordance with IFRS 11, “Joint Arrangements”.


(15)The Company does not have any equity interests in this entity, but has significant influence or control over it.

(16)Liquidated on March 23, 2022.

(17)Pursuant to the sale of the membership interests in DRANU, LLC, it ceased to be a joint venture effective March 31, 2021.